Elon's New Device Could Launch Biggest IPO of the Decade
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.
Uncertainty over federal food aid deepens as the shutdown fight reaches a crisis point
WASHINGTON (AP) — The crises at the heart of the in Washington were coming to a head Saturday as the faced delays and millions of Americans were set to see a dramatic rise in their .
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss
Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.
Taiwan reports its first case of African swine fever
TAIPEI, Taiwan (AP) — Taiwan reported its first cases of African swine fever on Wednesday and authorities culled at least 195 pigs and ordered a ban on the movement and slaughter of pigs across the island.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Some Head Start preschools shutter as government shutdown continues
The government shutdown is triggering a wave of closures of , leaving working parents scrambling for child care and shutting some of the nation's neediest children out of preschool.
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk
Pfizer is suing over in its nearly $5 billion bid to buy the drugmaker Metsera.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Intellia Therapeutics Stock Is Diving Again: Here's Why
Intellia Therapeutics shares are tumbling in after-hours trading on Wednesday. Here's what you need to know.
Study finds EVs quickly overcome their energy-intensive build to be cleaner than gas cars
DETROIT (AP) — Making electric vehicles and their batteries is a dirty process that uses a lot of energy. But a new study says that EVs quickly make up for that with through two years of use than a gas-powered vehicle.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
US appeals court overturns West Virginia landmark opioid lawsuit decision
CHARLESTON, W.Va. (AP) — A federal appeals court on Tuesday overturned a landmark decision in West Virginia that had rejected attempts by an opioid-ravaged area to be compensated by U.S. drug distributors for a influx of prescription pain pills into the region.
Vice President Vance says troops will be paid as pressure builds on Congress to end the shutdown
WASHINGTON (AP) — Vice President JD Vance said Tuesday he believes U.S. military members will be paid at the end of the week, though he did not specify how the Trump administration will reconfigure funding as pain from the second-longest shutdown spreads nationwide.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
UnitedHealth tops 3Q forecasts as it resets coverage prices to deal with rising costs
UnitedHealth has returned to better-than-expected growth after starting the year and then withdrawing its forecast for 2025.
4.9 million pounds of frozen, boneless chicken have been recalled
WASHINGTON (AP) — Hormel Foods is recalling nearly 4.9 million pounds of frozen boneless chicken products it sold to restaurants, cafeterias and other outlets, the U.S. Department of Agriculture's Food Safety and Inspection Service announced Saturday.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Centene And Oscar Health Stocks Sink After Molina Warning
US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guidance.
As heat gets more extreme, pregnant farmworkers are increasingly at risk
One hot day last summer, Clarisa Lugo was inspecting and counting corn and soybean plants in the middle of a 300-acre farm field in Illinois when she started throwing up and panting. Her heart raced, she stopped sweating and a pounding headache didn’t go away for hours.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Most Americans are concerned about higher health care costs next year, an AP-NORC poll finds
WASHINGTON (AP) — Most U.S. adults are worried about health care becoming more expensive, according to a new AP-NORC poll, as they make and keeps in limbo for millions.
How Americans are feeling about their chances on the job market, according to an AP-NORC poll
WASHINGTON (AP) — Americans are growing increasingly concerned about their ability to find a good job under , an Associated Press-NORC Center for Public Affairs poll finds, in what is a potential warning sign for Republicans as a promised has given way to and .
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength
Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.
Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy
Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson reports.
Elon's Haters Are About to Lose Their Minds... - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst
Johnson & Johnson raised its 2025 revenue guidance as Stelara erosion slowed, while BofA maintained a Neutral rating citing fair valuation.
Indonesia finds traces of radioactive element at clove farm
JAKARTA, Indonesia (AP) — Indonesia detected traces of radioactive cesium 137 at a clove plantation as it searches for the source of radioactive contamination that forced recalls of shrimp and spices exported to the U.S., a task force investigating the issue said Wednesday.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion.
Instagram says it's safeguarding teens by limiting them to PG-13 content
Teenagers on Instagram will be restricted to seeing PG-13 content by default and won't be able to change their settings without a parent's permission, Meta announced on Tuesday.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Government shutdown could be the longest ever, Speaker Johnson warns
WASHINGTON (AP) — Republican predicted Monday the federal may become the longest in history, saying he “won't negotiate” with Democrats until they hit pause on their and reopen.
CDC Reverses Hundreds Of Layoff Notices After Firing 1,300 Employees Amid Government Shutdown
The CDC laid off around 1,300 employees but reversed hundreds of notices within hours amid broader staffing disruptions during the shutdown.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Speaker Johnson keeps the House away as he fights to end the government shutdown
WASHINGTON (AP) — is the speaker of a House that is .
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.